NVO logo

Novo Nordisk A/S (NVO) Company Overview

Profile

Full Name:

Novo Nordisk A/S

Sector:

Healthcare

Industry:

Drug Manufacturers - General

Country:

Denmark

IPO:

April 30, 1981

Indexes:

Not included

Website:

http://www.novonordisk.com

Description:

Novo Nordisk A/S is a global healthcare company based in Denmark. It specializes in diabetes care, obesity treatment, and hormone replacement therapy. The company develops and produces innovative medicines and devices to improve patients' lives and focuses on sustainable practices in its operations.

Key Details

Price

$87.98

Market Cap

$390.55 B(Mega cap)

Last Dividend

$0.52

TTM Dividend Yield

1.64%

Annual Revenue

$42.13 B(+24.95% YoY)

Annual EPS

$3.28(+21.45% YoY)

PE Ratio

26.80

Annual ROE

81.76%

Annual Debt To Equity

0.67

Beta

0.63

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 5, 2025

Recent annual earnings:

Feb 5, 2025
Dividend

Next ex-dividend date:

Mar 31, 2025

Recent ex-dividend date:

Aug 16, 2024
Splits

Next split:

N/A

Recent split:

Sep 20, 2023

Analyst ratings

Recent major analysts updates

Jan 8, 25 UBS
Buy
Dec 23, 24 BMO Capital
Outperform
Nov 6, 24 Cantor Fitzgerald
Overweight
Oct 22, 24 Citigroup
Buy
Oct 17, 24 BMO Capital
Outperform
Oct 16, 24 Barclays
Overweight
Oct 14, 24 BMO Capital
Market Perform
Oct 10, 24 Jefferies
Buy
Oct 10, 24 Cantor Fitzgerald
Overweight
Sep 20, 24 Cantor Fitzgerald
Overweight

Screeners with NVO included

Stocks below SMA 200
Best performing stocks last 5 years
Stocks above SMA 50
Healthcare sector
Mega cap stocks
Companies with growing dividends
All stocks
High Altman Z score stocks
Companies with buyback
Best performing stocks last 15 years

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$87.98
NVO price is $87.98

Price All-time High

$147.78
NVO price is currently -40.47% below its historical high of $147.78

Price Analysts Target

-
NVO price consensus analysts' forecast is unknown

Price Most Recent Change

-0.25%
NVO price was down -0.25% on Mar 8, 2025

Price YTD Change

+2.42%
NVO price is up +2.42% since January 1st

Price 3-Year Change

+74.48%
NVO price is up +74.48% over the past 3 years

Market cap

Market Cap

$390.55 B
NVO market capitalization is $390.55 billion

Market Cap 3-Year Change

+70.17%
NVO market capitalization is up +70.17% over the past 3 years

Market Cap All-time High

$658.18 B
NVO market capitalization is currently -40.66% below its historical high of $658.18 billion

Market Cap Sector Rank

99.75%
NVO market capitalization is higher than 99.75% of companies in Healthcare sector

Technical

Beta

0.63
NVO beta is 0.63

200-day SMA

$115.55
NVO price is currently -23.86% below its 200-day simple moving average

14-day RSI

50.04
NVO 14-day relative strength index is 50.04

30-day Relative Volume

0.60
NVO 30-day relative volume is 0.60

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.52
NVO last dividend was $0.52 per share, with an ex-dividend date of August 16, 2024

Next Dividend

$1.10
NVO has announced a dividend of $1.10 per share, with an ex-dividend date set for March 31, 2025

Dividend per share

Annual Dividend Per Share

$1.45
NVO annual dividend per share is $1.45

Annual Dividend Per Share Sector Rank

56.47%
NVO annual dividend per share is higher than 56.47% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+40.17%
NVO annual dividend per share is up +40.17% year-on-year

Annual Dividend Per Share 3-Year Change

+96.51%
NVO annual dividend per share is up +96.51% over the past 3 years

Dividend yield

Annual Dividend Yield

1.64%
NVO annual dividend yield is 1.64%

Annual Dividend Yield Sector Rank

44.05%
NVO annual dividend yield is higher than 44.05% of companies in Healthcare sector

Other

Annual Payout Ratio

43.71%
NVO annual payout ratio is 43.71%

Annual Dividends Paid

$6.40 B
NVO annual dividends paid is $6.40 billion

Annual FCF

$10.11 B
NVO annual free cash flow is $10.11 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$42.13 B
NVO annual revenue is $42.13 billion

Annual Revenue Analysts Estimate

$352.18 B
NVO annual revenue is currently -88.04% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+24.95%
NVO annual revenue is up +24.95% year-on-year

Annual Revenue Sector Rank

97.62%
NVO annual revenue is higher than 97.62% of companies in Healthcare sector

Profit

Annual Gross Profit

$35.67 B
NVO annual gross profit is $35.67 billion

Annual Gross Margin

84.67%
NVO annual gross profit margin is 84.67%

Annual Operating Profit

$18.62 B
NVO annual operating income is $18.62 billion

Annual Operating Margin

44.19%
NVO annual operating profit margin is 44.19%

Annual Net Income

$14.65 B
NVO annual net profit is $14.65 billion

Annual Net Margin

34.78%
NVO annual net profit margin is 34.78%

EPS

Annual EPS

$3.28
NVO annual earnings per share is $3.28

Annual EPS Analysts Estimate

$27.36
NVO annual earnings per share is currently -88.00% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+21.45%
NVO annual earnings per share is up +21.45% year-on-year

Annual EPS Sector Rank

94%
NVO annual earnings per share is higher than 94% of companies in Healthcare sector

ROA & ROE

Annual ROA

26.24%
NVO annual return on assets is 26.24%

Annual ROE

81.76%
NVO annual return on equity is 81.76%

EBIT & EBITDA

Annual EBIT

$18.69 B
NVO annual earnings before interest & taxes is $18.69 billion

Annual EBITDA

$19.93 B
NVO annual EBITDA is $19.93 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

26.80
NVO price to earnings ratio is 26.80

PE Ratio Sector Rank

50.25%
NVO price to earnings ratio is higher than 50.25% of companies in Healthcare sector

PB Ratio

PB Ratio

19.51
NVO price to book ratio is 19.51

PB Ratio Sector Rank

96.13%
NVO price to book ratio is higher than 96.13% of companies in Healthcare sector

PS Ratio

PS Ratio

9.28
NVO price to sales ratio is 9.28

PS Ratio Sector Rank

77.31%
NVO price to sales ratio is higher than 77.31% of companies in Healthcare sector

Enterprise value

Enterprise Value

$402.70 B
NVO enterprise value is $402.70 billion

Enterprise Value Sector Rank

99.67%
NVO enterprise value is higher than 99.67% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.49
NVO EV/EBITDA is 18.49

EV/EBITDA Sector Rank

89.75%
NVO EV/EBITDA is higher than 89.75% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.74
NVO annual current ratio is 0.74

Annual Quick Ratio

0.55
NVO annual quick ratio is 0.55

Leverage

Annual Debt To Equity

0.67
NVO annual debt to equity ratio is 0.67

Annual Interest Coverage Ratio

78.56
NVO annual interest coverage ratio is 78.56

Risk & Stability

Piotroski F-Score

5
NVO piotroski f-score is 5

Altman Z-Score

7.10
NVO altman z-score is 7.10

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$64.99 B
NVO annual total assets is $64.99 billion

Annual Non Current Assets

$42.54 B
NVO annual long term assets is $42.54 billion

Annual Current Assets

$22.45 B
NVO annual total current assets is $22.45 billion

Annual Cash & Cash Equivalents

$2.18 B
NVO annual cash & cash equivalents is $2.18 billion

Equity

Annual Book Value

$20.02 B
NVO annual book value is $20.02 billion

Annual Working Capital

-$7.90 B
NVO annual working capital is -$7.90 billion

Liabilities

Annual Total Liabilities

$44.97 B
NVO annual total liabilities is $44.97 billion

Annual Total Long Term Liabilities

$14.62 B
NVO annual total long term liabilities is $14.62 billion

Annual Current Liabilities

$30.35 B
NVO annual total current liabilities is $30.35 billion

Annual Accounts Payable

$4.02 B
NVO annual accounts payable is $4.02 billion

Debt

Annual Total Debt

$14.34 B
NVO annual total debt is $14.34 billion

Annual Total Debt 1-Year Change

+257.65%
NVO annual total debt is up +257.65% year-on-year

Annual Long Term Debt

$12.51 B
NVO annual long term debt is $12.51 billion

Annual Short Term Debt

$1.83 B
NVO annual short term debt is $1.83 billion

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$23.51 B
NVO annual total expenses is $23.51 billion

Annual Operating Expenses

$17.05 B
NVO annual total operating expenses is $17.05 billion

Annual Cost Of Goods Sold

$6.46 B
NVO annual cost of goods sold is $6.46 billion

Annual SGA

$9.78 B
NVO annual SGA is $9.78 billion

Annual D&A

$1.24 B
NVO annual depreciation & amortization is $1.24 billion

Annual Interest Expense

$237.95 M
NVO annual interest expense is $237.95 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$17.55 B
NVO annual cash flow from operations is $17.55 billion

Annual CFO 1-Year Change

+11%
NVO annual cash flow from operations is up +11% year-on-year

Annual CFI

-$18.70 B
NVO annual cash flow from investing activities is -$18.70 billion

Annual CFI 1-Year Change

-193.47%
NVO annual cash flow from investing activities is down -193.47% year-on-year

Annual CFF

$1.27 B
NVO annual cash flow from financing activities is $1.27 billion

Annual CFF 1-Year Change

+113.82%
NVO annual cash flow from financing activities is up +113.82% year-on-year

Free CashFlow

Annual FCF

$10.11 B
NVO annual free cash flow is $10.11 billion

Annual FCF 1-Year Change

-0.57%
NVO annual free cash flow is down -0.57% year-on-year

CAPEX

Annual CAPEX

$7.44 B
NVO annual capital expenditures is $7.44 billion

Annual CAPEX 1-Year Change

+31.82%
NVO annual capital expenditures is up +31.82% year-on-year

Institutional Ownership

Similar stocks

JNJ logo
Johnson & Johnson (JNJ)
ABBV logo
AbbVie (ABBV)
UNH logo
UnitedHealth Group Incorporated (UNH)
AZN logo
AstraZeneca (AZN)
MRK logo
Merck & Co (MRK)
ABT logo
Abbott Laboratories (ABT)
NVS logo
Novartis AG (NVS)
TMO logo
Thermo Fisher Scientific (TMO)
ISRG logo
Intuitive Surgical (ISRG)

FAQ

  • What is the ticker symbol for Novo Nordisk A/S?
  • Does Novo Nordisk A/S pay dividends?
  • What sector is Novo Nordisk A/S in?
  • What industry is Novo Nordisk A/S in?
  • What country is Novo Nordisk A/S based in?
  • When did Novo Nordisk A/S go public?
  • Is Novo Nordisk A/S in the S&P 500?
  • Is Novo Nordisk A/S in the NASDAQ 100?
  • Is Novo Nordisk A/S in the Dow Jones?
  • When was Novo Nordisk A/S's last earnings report?
  • When does Novo Nordisk A/S report earnings?

What is the ticker symbol for Novo Nordisk A/S?

The ticker symbol for Novo Nordisk A/S is NYSE:NVO

Does Novo Nordisk A/S pay dividends?

Yes, Novo Nordisk A/S pays dividends. The last payment was $0.52, with an ex-dividend date on August 16, 2024

What sector is Novo Nordisk A/S in?

Novo Nordisk A/S is in the Healthcare sector

What industry is Novo Nordisk A/S in?

Novo Nordisk A/S is in the Drug Manufacturers - General industry

What country is Novo Nordisk A/S based in?

Novo Nordisk A/S is headquartered in Denmark

When did Novo Nordisk A/S go public?

Novo Nordisk A/S's initial public offering (IPO) was on April 30, 1981

Is Novo Nordisk A/S in the S&P 500?

No, Novo Nordisk A/S is not included in the S&P 500 index

Is Novo Nordisk A/S in the NASDAQ 100?

No, Novo Nordisk A/S is not included in the NASDAQ 100 index

Is Novo Nordisk A/S in the Dow Jones?

No, Novo Nordisk A/S is not included in the Dow Jones index

When was Novo Nordisk A/S's last earnings report?

Novo Nordisk A/S's most recent earnings report was on Feb 5, 2025

When does Novo Nordisk A/S report earnings?

The next expected earnings date for Novo Nordisk A/S is May 7, 2025